Driver mutations of cancer epigenomes
Epigenetic alterations are associated with all aspects of cancer, from tumor initiation to
cancer progression and metastasis. It is now well understood that both losses and gains of …
cancer progression and metastasis. It is now well understood that both losses and gains of …
[HTML][HTML] Pan-cancer alterations of the MYC oncogene and its proximal network across the cancer genome atlas
FX Schaub, V Dhankani, AC Berger, M Trivedi… - Cell systems, 2018 - cell.com
Although the MYC oncogene has been implicated in cancer, a systematic assessment of
alterations of MYC, related transcription factors, and co-regulatory proteins, forming the …
alterations of MYC, related transcription factors, and co-regulatory proteins, forming the …
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
T Picart, M Barritault, D Poncet, LP Berner… - Neuro-Oncology …, 2021 - academic.oup.com
Background Diffuse hemispheric gliomas, H3 G34-mutant (DHG H3G34-mutant) constitute a
distinct type of aggressive brain tumors. Although initially described in children, they can …
distinct type of aggressive brain tumors. Although initially described in children, they can …
A drug repurposing screen identifies fludarabine phosphate as a potential therapeutic agent for N-MYC overexpressing neuroendocrine prostate cancers
H Elhasasna, R Khan, KK Bhanumathy… - Cells, 2022 - mdpi.com
Neuroendocrine prostate cancer (NEPC) represents a highly aggressive form of prostate
tumors. NEPC results from trans-differentiated castration-resistant prostate cancer (CRPC) …
tumors. NEPC results from trans-differentiated castration-resistant prostate cancer (CRPC) …
Molecular diagnostic and prognostic subtyping of gliomas in tunisian population
S Trabelsi, I Chabchoub, I Ksira, N Karmeni… - Molecular …, 2017 - Springer
It has become increasingly evident that morphologically similar gliomas may have distinct
clinical phenotypes arising from diverse genetic signatures. To date, glial tumours from the …
clinical phenotypes arising from diverse genetic signatures. To date, glial tumours from the …
Histone H3G34 mutation in brain and bone tumors
L Qiu, J Han - Histone Mutations and Cancer, 2021 - Springer
H3G34 mutations occur in both pediatric non-brainstem high-grade gliomas (G34R/V) and
giant cell tumors of bone (G34W/L). Glioblastoma patients with G34R/V mutation have a …
giant cell tumors of bone (G34W/L). Glioblastoma patients with G34R/V mutation have a …
The Histone Mutational Landscape in Paediatric Brain Tumours
SSW Zhong - 2023 - search.proquest.com
Paediatric brain tumours (PBTs) are one of the most common cancers in children. Whilst
histone mutations, such as H3K27M and H3G34R/V, have been identified as major drivers …
histone mutations, such as H3K27M and H3G34R/V, have been identified as major drivers …
[PDF][PDF] Neuro-Oncology Advances
T Picart, M Barritault, D Poncet, LP Berner, C Izquierdo… - 2021 - hal.sorbonne-universite.fr
Background. Diffuse hemispheric gliomas, H3 G34-mutant (DHG H3G34-mutant) constitute
a distinct type of aggressive brain tumors. Although initially described in children, they can …
a distinct type of aggressive brain tumors. Although initially described in children, they can …
Analyse von Gliomen bezüglich ihrer Olig2-und FoxG1-Expressionsverhalten und deren Zusammenhang mit H3F3A-Mutationen
S Schäfer - 2020 - tobias-lib.ub.uni-tuebingen.de
Diffuse Gliome zeigen insgesamt eine eher schlechte Prognose, was unter anderem auf
intratumorale Heterogenität zurückzuführen ist. Molekulare Marker helfen dabei …
intratumorale Heterogenität zurückzuführen ist. Molekulare Marker helfen dabei …